IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA

IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA was reported 252 times

IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 KALEIDOSCOPE VISION 1 0.0312
1 PRIMARY IMMUNODEFICIENCY SYNDROME 1 0.0123
2 SHUNT THROMBOSIS 1 0.0101
3 MIDDLE CEREBRAL ARTERY STROKE 1 0.0088
4 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 1 0.0066
5 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1 0.0057
6 CEREBRAL MASS EFFECT 1 0.0028
7 PERIPHERAL CIRCULATORY FAILURE 1 0.0024
8 HYPERTENSIVE URGENCY 1 0.0018
9 HYPERTENSIVE EMERGENCY 2 0.0017
10 INFUSION SITE URTICARIA 1 0.0015
11 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
12 TONGUE PRURITUS 1 0.0012
13 TRANSFUSION REACTION 1 0.0011
14 ANAPHYLACTOID REACTION 4 0.0010
15 CHRONIC RESPIRATORY FAILURE 1 0.0008
16 INFUSION RELATED REACTION 49 0.0007
17 URTICARIA 122 0.0007
18 NOROVIRUS INFECTION 1 0.0007
19 PULMONARY SEPSIS 1 0.0007
20 MENINGITIS ASEPTIC 3 0.0007
21 PHARYNGEAL PARAESTHESIA 1 0.0006
22 COSTOCHONDRITIS 1 0.0006
23 LIP SWELLING 19 0.0006
24 AORTIC VALVE STENOSIS 1 0.0006
25 ANAL PRURITUS 1 0.0005
26 SENSATION OF FOREIGN BODY 4 0.0005
27 ORAL PRURITUS 1 0.0004
28 PUSTULE 1 0.0004
29 PHARYNGEAL SWELLING 4 0.0004
30 HYPERVOLAEMIA 2 0.0004
31 PARTIAL SEIZURES 2 0.0004
32 METABOLIC DISORDER 2 0.0003
33 INFUSION SITE REACTION 1 0.0003
34 RESPIRATORY ACIDOSIS 1 0.0003
35 LIP OEDEMA 1 0.0002
36 EAR DISORDER 1 0.0002
37 RECALLED PRODUCT ADMINISTERED 2 0.0002
38 RASH VESICULAR 1 0.0002
39 PRURITUS 78 0.0002
40 VULVOVAGINAL PRURITUS 1 0.0002
41 MOTOR DYSFUNCTION 2 0.0002
42 NONSPECIFIC REACTION 1 0.0002
43 HYPERTENSIVE CRISIS 2 0.0002
44 PERIORBITAL SWELLING 1 0.0002
45 MOUTH SWELLING 1 0.0002
46 SWELLING FACE 11 0.0002
47 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
48 POLYNEUROPATHY 2 0.0002
49 ANAPHYLACTIC REACTION 9 0.0002
50 LARYNGEAL OEDEMA 1 0.0002
51 DERMATITIS ALLERGIC 2 0.0002
52 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
53 PAPULE 1 0.0001
54 ANGIOEDEMA 6 0.0001
55 RASH 59 0.0001
56 TENDON PAIN 1 0.0001
57 HAEMOLYSIS 1 0.0001
58 NASAL DISCOMFORT 1 0.0001
59 MIOSIS 1 0.0001
60 PSEUDOMONAS INFECTION 1 0.0001
61 COLD SWEAT 2 0.0001
62 HAEMOLYTIC ANAEMIA 1 0.0001
63 THROAT IRRITATION 5 0.0001
64 RASH PRURITIC 6 0.0001
65 UROSEPSIS 1 0.0001
66 CHEST DISCOMFORT 11 0.0001
67 HYPERSENSITIVITY 19 0.0001
68 SALIVARY HYPERSECRETION 1 0.0001
69 FLUSHING 9 0.0001
70 WHEEZING 5 0.0001
71 CHILLS 9 0.0001
72 JAUNDICE 2 0.0001
73 THROAT TIGHTNESS 2 0.0001
74 TACHYPNOEA 1 0.0001
75 PALLOR 2 0.0001
76 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
77 PAIN IN JAW 2 0.0001
78 PARAESTHESIA ORAL 1 0.0001
79 HAEMORRHAGE INTRACRANIAL 1 0.0001
80 ERYTHEMA 13 0.0001
81 RASH ERYTHEMATOUS 3 0.0001
82 CHEST PAIN 11 0.0001
83 MUSCULOSKELETAL DISCOMFORT 1 0.0001
84 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
85 HEAD DISCOMFORT 1 0.0001
86 THIRST 1 0.0001
87 PELVIC PAIN 1 0.0001
88 EAR PAIN 1 0.0001
89 CYTOKINE RELEASE SYNDROME 1 0.0000
90 TASTE DISORDER 1 0.0000
91 BODY TEMPERATURE INCREASED 1 0.0000
92 PRODUCT PREPARATION ERROR 1 0.0000
93 PULMONARY OEDEMA 2 0.0000
94 ORAL PAIN 1 0.0000
95 SNEEZING 1 0.0000
96 CHROMATURIA 1 0.0000
97 PRODUCTIVE COUGH 2 0.0000
98 SKIN BURNING SENSATION 3 0.0000
99 ABDOMINAL PAIN LOWER 1 0.0000
100 THERAPY CESSATION 2 0.0000
101 OFF LABEL USE 34 0.0000
102 UNRESPONSIVE TO STIMULI 1 0.0000
103 ECZEMA 2 0.0000
104 SPEECH DISORDER 2 0.0000
105 DYSPNOEA 21 0.0000
106 HEADACHE 23 0.0000
107 SKIN LESION 1 0.0000
108 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
109 BLISTER 2 0.0000
110 ANGINA PECTORIS 1 0.0000
111 PANCREATIC CARCINOMA 1 0.0000
112 ACUTE MYOCARDIAL INFARCTION 1 0.0000
113 LACRIMATION INCREASED 1 0.0000
114 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
115 FEELING HOT 2 0.0000
116 SWOLLEN TONGUE 1 0.0000
117 DYSPHAGIA 3 0.0000
118 METABOLIC ACIDOSIS 1 0.0000
119 MOVEMENT DISORDER 1 0.0000
120 HYPERHIDROSIS 4 0.0000
121 HEART RATE INCREASED 3 0.0000
122 TREMOR 5 0.0000
123 BLOOD PRESSURE DECREASED 2 0.0000
124 SKIN DISORDER 1 0.0000
125 EYE PRURITUS 1 0.0000
126 NAUSEA 23 0.0000
127 RASH MACULAR 1 0.0000
128 HEART RATE DECREASED 1 0.0000
129 RESTLESSNESS 1 0.0000
130 EYE SWELLING 1 0.0000
131 BLOOD PRESSURE INCREASED 4 0.0000
132 SEIZURE 3 0.0000
133 PALPITATIONS 3 0.0000
134 DISORIENTATION 1 0.0000
135 VOMITING 11 0.0000
136 BALANCE DISORDER 2 0.0000
137 SEPTIC SHOCK 1 0.0000
138 MUSCULOSKELETAL STIFFNESS 2 0.0000
139 TACHYCARDIA 2 0.0000
140 TINNITUS 1 0.0000
141 SKIN DISCOLOURATION 1 0.0000
142 BACK PAIN 5 0.0000
143 COUGH 6 0.0000
144 ARRHYTHMIA 1 0.0000
145 OCULAR HYPERAEMIA 1 0.0000
146 DYSPEPSIA 2 0.0000
147 HYPOTENSION 4 0.0000
148 PERIPHERAL SWELLING 3 0.0000
149 ABDOMINAL PAIN UPPER 4 0.0000
150 ABDOMINAL DISTENSION 2 0.0000
151 TREATMENT NONCOMPLIANCE 1 0.0000
152 NECK PAIN 1 0.0000
153 OXYGEN SATURATION DECREASED 1 0.0000
154 LETHARGY 1 0.0000
155 PRODUCT SUBSTITUTION ISSUE 1 0.0000
156 DYSPHONIA 1 0.0000
157 DISCOMFORT 1 0.0000
158 MALAISE 7 0.0000
159 PRODUCT QUALITY ISSUE 2 0.0000
160 HYPERTENSION 3 0.0000
161 RESPIRATORY FAILURE 1 0.0000
162 EPISTAXIS 1 0.0000
163 HYPOAESTHESIA 2 0.0000
164 ASTHENIA 5 0.0000
165 ACUTE KIDNEY INJURY 2 0.0000
166 DECREASED APPETITE 3 0.0000
167 CARDIAC FAILURE CONGESTIVE 1 0.0000
168 INFLUENZA LIKE ILLNESS 1 0.0000
169 FATIGUE 9 0.0000
170 SWELLING 1 0.0000
171 MIGRAINE 1 0.0000
172 ATRIAL FIBRILLATION 1 0.0000
173 DIZZINESS 5 0.0000
174 SOMNOLENCE 2 0.0000
175 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
176 INJECTION SITE ERYTHEMA 1 0.0000
177 LOSS OF CONSCIOUSNESS 1 0.0000
178 NEUTROPENIA 1 0.0000
179 ANXIETY 2 0.0000
180 PAIN IN EXTREMITY 2 0.0000
181 ABDOMINAL DISCOMFORT 1 0.0000
182 MYALGIA 1 0.0000
183 PYREXIA 2 0.0000
184 ARTHRALGIA 2 0.0000
185 DIARRHOEA 3 0.0000
186 ABDOMINAL PAIN 1 0.0000
187 FEELING ABNORMAL 1 0.0000
188 PAIN 2 0.0000
189 DRUG INEFFECTIVE 2 0.0000